Bon Natural Life Ltd logo

Bon Natural Life Ltd(BON)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.1
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for BON

11/13/2026: BON (1-star) is currently NOT-A-BUY. Pass it for now.

Bon Natural Life Ltd is a small-cap specialty chemicals company that manufactures plant-derived fragrance compounds and bioactive food ingredients for global markets. While the company benefits from structural consumer trends favoring clean-label natural products and holds established distribution relationships, its financial performance has been marred by volatile revenues, razor-thin profit margins, and negative free cash flows. The primary investment story rests on its potential to capture niche botanical extract demand, which is heavily counterbalanced by intense competition from multinational giants and execution risks. The stock represents a high-risk micro-cap opportunity best suited for speculative participants rather than conservative investors. Market participants should closely monitor upcoming quarterly cash burn trends, margin recoveries, and export demand stability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitUnpredictable revenue growth and modest scale limit its appeal for dedicated growth strategies.
Momentum investorWeak fitLow trading volume and historical downward price trends mean momentum conditions are generally absent.
Value investorMixed fitLow price-to-book multiples exist, but fundamental business instability offsets deep-value appeal.
Dividend investorWeak fitThe company does not provide reliable income or robust dividend yields.
Low-risk investorWeak fitMicro-cap volatility, cash flow burn, and intense market competition create high risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighMicro-cap status and low float lead to sharp intraday and historical price swings.
Valuation riskMedium / highLow valuation multiples can trap value-seeking investors if underlying earnings deteriorate further.
Competition risk (global ingredient giants)HighMassive competitors dominate flavor, fragrance, and botanical extract supply chains.
Business qualityMedium / highThin profit margins and negative free cash flows highlight operational fragility.
Dividend incomeLow / noneThe stock does not support an income-generating investment thesis.
Execution riskHighManagement must navigate tight liquidity while executing product sales in competitive markets.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 8.99M USD
Price to earnings Ratio -
1Y Target Price 77.5
Price to earnings Ratio -
1Y Target Price 77.5
Volume (30-day avg) 10.2K shares
Beta -0.25
52 Weeks Range 0.95 - 1.94
Updated Date 11/15/2026
52 Weeks Range 0.95 - 1.94
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -2.79

Sector & Industry Intelligence

Sector

Basic Materials

Defensive
Sentiment
Bearish
Momentum
Momentum Steady
BUY participation
23.1%
Active BUY / eligible
9 / 39
30-Day BUY Count Change
+2
Market state
Bearish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Specialty Chemicals

BUY participation
57.1%
Active BUY / eligible
4 / 7
30-Day BUY Count Change
+1

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -20.42%
Avg. Invested days 19
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
BON receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft company fundamentals, and soft analyst coverage.

Company Fundamentals

★★★★★
BON has soft overall fundamentals (2 stars), with soft financial health, soft growth momentum, and moderate ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-601.0%), weak cash generation (FCF margin -22.7%), negative revenue growth (-21.7%).

Financial Health Rating

★★★★★
BON's financial health is soft, with the relatively strongest area being moderate liquidity, including working-capital and asset support (WC/assets 22.8%). Profitability is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is BON's strongest growth driver at +45.3% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (-21.7%, negative) and earnings growth (-601.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 0.6% (soft) and 98.6% of outstanding shares are publicly tradable (strong). Insider ownership is only 0.04%, which materially reduces the ownership score.

Top 5 Institutional Investors

XTX Topco Ltd 0.19%
Citadel Advisors Llc 0.15%
TWO SIGMA SECURITIES, LLC 0.13%
UBS Group AG 0.01%
Caitong International Asset Management Co., Limited. 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
BON generates approximately $208 of gross profit, $-87 of operating income, and $-227 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -19.85% (Tax Credit)

Quantitative Style Profile

★★★★★
BON has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Personal Care IngredientsPlant-extracted fragrance compounds sold to perfume and cosmetic manufacturers.Provides specialized aromatic inputs for consumer beauty products.
Natural Health SupplementsBioactive food ingredients and powder drinks utilized as food additives.Generates revenue from wellness and nutritional supplement markets.
Geographic MarketsSales derived from the People's Republic of China, Europe, North America, and the Middle East.Exposes the company to both domestic Asian demand and international export channels.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Valuation

Trailing PE -
Forward PE 2.35
Enterprise Value 15.53M
Price to Sales(TTM) 0.48
Enterprise Value 15.53M
Price to Sales(TTM) 0.48
Enterprise Value to Revenue 0.83
Enterprise Value to EBITDA 2.9
Shares Outstanding 6.13M
Shares Floating 6.04M
Shares Outstanding 6.13M
Shares Floating 6.04M
Percent Insiders 0.04
Percent Institutions 0.65

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.